Emerging Opportunities for Inhaled Antibiotic Therapy
نویسندگان
چکیده
منابع مشابه
Emerging Opportunities for Inhaled Antibiotic Therapy
Inhaled antibiotic therapy has transformed cystic fibrosis (CF) disease progression by delaying the onset of chronic infection with Pseudomonas aeruginosa (PA), reducing the rate of decline of lung function, improving the quality of life (QoL), and reducing exacerbations and hospital admissions [1]. Aggressive use of antibiotic regimens at first detection of PA infection in CF patients may dela...
متن کاملEmerging Opportunities for Inhaled Antibiotic Therapy
Inhaled antibiotic therapy has transformed cystic fibrosis (CF) disease progression by delaying the onset of chronic infection with Pseudomonas aeruginosa (PA), reducing the rate of decline of lung function, improving the quality of life (QoL), and reducing exacerbations and hospital admissions [1]. Aggressive use of antibiotic regimens at first detection of PA infection in CF patients may dela...
متن کاملAntitubercular inhaled therapy: opportunities, progress and challenges.
Pulmonary tuberculosis remains the commonest form of this disease and the development of methods for delivering antitubercular drugs directly to the lungs via the respiratory route is a rational therapeutic goal. The obvious advantages of inhaled therapy include direct drug delivery to the diseased organ, targeting to alveolar macrophages harbouring the mycobacteria, reduced risk of systemic to...
متن کاملInhaled Antibiotic Therapy in Chronic Respiratory Diseases
The management of patients with chronic respiratory diseases affected by difficult to treat infections has become a challenge in clinical practice. Conditions such as cystic fibrosis (CF) and non-CF bronchiectasis require extensive treatment strategies to deal with multidrug resistant pathogens that include Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus, Burkholderia specie...
متن کاملSteroid-decorated antibiotic microparticles for inhaled anti-infective therapy.
Despite advances in vaccination and antimicrobial therapy, community-acquired pneumonia (CAP) remains as a leading cause of morbidity and mortality worldwide. As the severity of CAP has been linked to the extent of inflammation in the body, adjunctive therapeutic measures aimed at modulating the immune response have therefore become increasingly attractive in recent years. In particular, for CA...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Antimicrobial Agents
سال: 2015
ISSN: 2472-1212
DOI: 10.4172/2472-1212.1000104